Access Bio gets FDA emergency authorization for quick Covid-19 test

Access Bio, biopharma nl, CareStart, coronavirus, COVID-19, Diagnostics, New Jersey, SARS-CoV-2, Somerset / July 23, 2020

The company said the CareStart Covid-19 MDx RT-PCR test is designed to detect RNA from the SARS-CoV-2 virus and produce results within 83 minutes.